BIOMAT Database Logo BIOMAT Database Logo

[Changes effected in "Serratia marcescens" from treatment with eritrocina (author's transl)]. 1978

M Cerbo, and R Vecchione

UI MeSH Term Description Entries
D007740 L Forms Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.
D010860 Pigments, Biological Any normal or abnormal coloring matter in PLANTS; ANIMALS or micro-organisms. Biological Pigments
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D012706 Serratia marcescens A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.

Related Publications

M Cerbo, and R Vecchione
[Serratia marcescens (author's transl)].
September 1979, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
M Cerbo, and R Vecchione
[Antibody detection in infections with Serratia marcescens (author's transl)].
January 1975, Infection,
M Cerbo, and R Vecchione
[Nuclease-antibodies in infections with Serratia marcescens (author's transl)].
August 1979, Immunitat und Infektion,
M Cerbo, and R Vecchione
[Serratia marcescens infection in intensive care units (author's transl)].
June 1975, Praktische Anasthesie, Wiederbelebung und Intensivtherapie,
M Cerbo, and R Vecchione
[Contribution to the experimental Serratia marcescens infection (author's transl)].
March 1980, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
M Cerbo, and R Vecchione
["Serratia marcescens" in neonatology: epidemiology of a hazard (author's transl)].
January 1980, Journal de gynecologie, obstetrique et biologie de la reproduction,
M Cerbo, and R Vecchione
[Pili-mediated agglutination of Serratia marcescens in human urine (author's transl)].
January 1981, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Cerbo, and R Vecchione
[Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
October 1977, The Japanese journal of antibiotics,
M Cerbo, and R Vecchione
[A case of brain abscess due to Serratia marcescens (author's transl)].
July 1979, No shinkei geka. Neurological surgery,
M Cerbo, and R Vecchione
[Serratia marcescens in bovine mastitis. Bibliography and a case study (author's transl)].
December 1977, Nordisk veterinaermedicin,
Copied contents to your clipboard!